Clinical Trial Update: Staccato Prochlorperazine in Migraine (in Clinic) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Staccato prochlorperazine in migraine patients (with or without aura) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Headache

Drugs mentioned

• Staccato Prochlorperazine (prochlorperazine)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Migraine Headache, With or Without Aura | Phase 2 | Status: COMPLETED | Results posted: 2018-01-25